எலெனா கலெ News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from எலெனா கலெ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In எலெனா கலெ Today - Breaking & Trending Today
Reactive Astrocytes Boot Basic, Dysfunctional Lysosomes alzforum.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alzforum.org Daily Mail and Mail on Sunday newspapers.
19 Dec 2020 The anti-inflammatory medication masitinib met its primary endpoint in an Alzheimer’s disease trial, according to topline data announced December 16 by its sponsor, the Paris-based company AB Science. In the six-month Phase 2b/3 study of 718 AD patients, the drug appeared to halt cognitive decline, with the treatment group, on average, notching slight improvements on the ADAS-Cog. In addition, fewer patients on drug than placebo progressed to severe dementia. The trial, which started seven years ago, did not include any biomarker data. Masitinib maintained cognition and function in people with mild to moderate AD. The drug is believed to dampen inflammation via microglia and mast cells. ....